293 related articles for article (PubMed ID: 29636181)
1. Antigen processing and presentation in HIV infection.
Boucau J; Le Gall S
Mol Immunol; 2019 Sep; 113():67-74. PubMed ID: 29636181
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
Becker Y
Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
[TBL] [Abstract][Full Text] [Related]
3. The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.
Boucau J; Madouasse J; Kourjian G; Carlin CS; Wambua D; Berberich MJ; Le Gall S
J Immunol; 2019 May; 202(10):2856-2872. PubMed ID: 30936293
[TBL] [Abstract][Full Text] [Related]
4. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
[TBL] [Abstract][Full Text] [Related]
5. Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.
Reguzova AY; Karpenko LI; Mechetina LV; Belyakov IM
Expert Rev Vaccines; 2015 Jan; 14(1):69-84. PubMed ID: 25373312
[TBL] [Abstract][Full Text] [Related]
6. Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.
Qiao C; Liu J; Yang J; Li Y; Weng J; Shao Y; Zhang X
Biomaterials; 2016 Apr; 85():1-17. PubMed ID: 26851653
[TBL] [Abstract][Full Text] [Related]
7. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
[TBL] [Abstract][Full Text] [Related]
8. Species-specific CD1-restricted innate immunity for the development of HIV vaccine.
Takahashi H
Vaccine; 2010 May; 28 Suppl 2():B3-7. PubMed ID: 20510740
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
Carlson JM; Le AQ; Shahid A; Brumme ZL
Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
[TBL] [Abstract][Full Text] [Related]
10. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.
Coulon PG; Richetta C; Rouers A; Blanchet FP; Urrutia A; Guerbois M; Piguet V; Theodorou I; Bet A; Schwartz O; Tangy F; Graff-Dubois S; Cardinaud S; Moris A
J Immunol; 2016 Jul; 197(2):517-32. PubMed ID: 27288536
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat vaccines.
Ensoli B; Cafaro A
Virus Res; 2002 Jan; 82(1-2):91-101. PubMed ID: 11885958
[No Abstract] [Full Text] [Related]
12. Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.
Rucevic M; Kourjian G; Boucau J; Blatnik R; Garcia Bertran W; Berberich MJ; Walker BD; Riemer AB; Le Gall S
J Virol; 2016 Oct; 90(19):8605-20. PubMed ID: 27440904
[TBL] [Abstract][Full Text] [Related]
13. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
14. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
[TBL] [Abstract][Full Text] [Related]
16. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
Berzofsky JA
Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
[TBL] [Abstract][Full Text] [Related]
17. A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses.
Malnati MS; Heltai S; Cosma A; Reitmeir P; Allgayer S; Glashoff RH; Liebrich W; Vardas E; Imami N; Westrop S; Nozza S; Tambussi G; Buttò S; Fanales-Belasio E; Ensoli B; Ensoli F; Tripiciano A; Fortis C; Lusso P; Poli G; Erfle V; Holmes H
J Immunol Methods; 2012 Jan; 375(1-2):46-56. PubMed ID: 21963950
[TBL] [Abstract][Full Text] [Related]
18. Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1.
Sabado RL; Babcock E; Kavanagh DG; Tjomsland V; Walker BD; Lifson JD; Bhardwaj N; Larsson M
Eur J Immunol; 2007 Jul; 37(7):1752-63. PubMed ID: 17534864
[TBL] [Abstract][Full Text] [Related]
19. Concerning the anti-major histocompatibility complex approach to HIV type 1 vaccine design.
Luscher MA; Dela Cruz CS; MacDonald KS; Barber BH
AIDS Res Hum Retroviruses; 1998 May; 14(7):541-4. PubMed ID: 9591707
[No Abstract] [Full Text] [Related]
20. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.
Wilson CC; Palmer B; Southwood S; Sidney J; Higashimoto Y; Appella E; Chesnut R; Sette A; Livingston BD
J Virol; 2001 May; 75(9):4195-207. PubMed ID: 11287569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
